Overview
Watchlist
Equities
Crypto
Soon
Popular
Home
Equities
IPHA
Fundamentals

Innate Pharma Sa

IPHA

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

20.12M
▼-41.52M▼-67.36%
12 Months Change

Assets

92.94M
▼-18.12M▼-16.32%
6 Months Change

Liabilities

0.00
0.000.00%
-

Free Cash Flow

-7.29M
▲25.62M▲77.86%
12 Months Change

Revenue/Cost Of Revenue

Net Profit/Loss

Assets/Liabilities

Cash Flows

Earnings Per Share

Outstanding Shares

Recent Quarterly and Annual Filings

2024-04-04
Form 20-F
ID: 0001598599-24-000020
2023-04-06
Form 20-F
ID: 0001628280-23-010946
2022-04-04
Form 20-F
ID: 0001628280-22-008197
2021-04-27
Form 20-F
ID: 0001628280-21-007629
2020-04-24
Form 20-F
ID: 0001171843-20-002847